Washington Capital Management Inc Gsk PLC Transaction History

Washington Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 18, 2023	BUY	$42.05 - $47.77 $532,983 - $605,484	12,675 Added 203.61%	18,900 $838,000
Q1 2022 Sep 18, 2023	SELL	$40.23 - $47.74 $10,057 - $11,935	-250 Reduced 3.86%	6,225 $276,000
Q4 2021 Sep 18, 2023	SELL	$38.88 - $45.31 $17,301 - $20,162	-445 Reduced 6.43%	6,475 $291,000
Q3 2021 Sep 18, 2023	BUY	$38.79 - $43.16 $268,426 - $298,667	6,920 New	6,920 $269,000
Q1 2021 May 04, 2021	BUY	$34.27 - $40.01 $41,638 - $48,612	1,215 Added 19.24%	7,530 $269,000
Q4 2020 Feb 05, 2021	BUY	$34.07 - $39.94 $215,152 - $252,221	6,315 New	6,315 $232,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Washington Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Washington Capital Management Inc with notifications on news.